Senate Bill 2408 Could Expand Medical Cannabis Use in Hawaii Hospitals

9 March 2026

Hawaii’s Senate has approved legislation that could reshape how medical cannabis is used in health care environments across the state. Senate Bill 2408, titled the Compassionate Access to Medical Cannabis Act or Ryan’s Law, outlines a framework allowing certain patients to use cannabis in specified facilities while maintaining a range of clinical and regulatory safeguards.

The measure is designed to support terminally ill patients and qualifying patients over age sixty five who have chronic diseases. Under the proposed law, facilities such as general acute care hospitals, hospice homes, skilled nursing facilities, and congregate living health facilities could adopt policies permitting cannabis use, provided that consumption methods exclude smoking or vaping in most cases. In home health settings, restrictions on inhaled use would apply primarily when staff are present.

The bill requires that cannabis use be documented in patient medical records and that patients or caregivers handle procurement, administration, and secure storage. Health care professionals would not be permitted to administer or retrieve cannabis. Facilities that opt to allow use would need to develop written guidelines and provide staff training, though compliance with the chapter would not be tied to facility licensing requirements.

At the same time, the legislation includes limitations intended to address federal legal uncertainties. Health care institutions could suspend participation if federal agencies initiate enforcement actions or issue directives conflicting with state medical cannabis policies. Certain settings, including emergency departments and substance misuse treatment centers, would be excluded from the law’s scope.

The Senate’s action on SB 2408 comes amid a broader legislative environment where cannabis policy proposals have seen mixed outcomes. While efforts to legalize adult use have stalled in the House in recent sessions, lawmakers continue to advance targeted measures affecting medical access, product regulations, and expungement processes. Recent policy developments have included changes to caregiver cultivation rules, updates to hemp product oversight, and expanded dispensary product offerings.

For Hawaii’s medical cannabis patients, the proposed law may clarify how treatment continuity is managed during institutional care. Yet its permissive structure means that actual access could depend on facility level decisions and internal policy development. As the measure moves through the legislative process alongside a House companion bill, its practical impact may hinge on how health care providers balance patient needs with regulatory considerations.